Impaired physical health among methamphetamine users in comparison with the general population: the role of methamphetamine dependence and opioid use

References

• Karch S B, Stephens B G, Ho C H. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicological profiles. J Forensic Sci 1999; 44: 359–368
   PubMed Web of Science ®Google Scholar
• Richards J R, Johnson E B, Stark R W, Derlet R W. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med 1999; 17: 681–685
   PubMed Web of Science ®Google Scholar
• Tokunaga I, Kubo S, Ishigami A, Gotohda T, Kitamura O. Changes in renal function and oxidative damage in methamphetamine-treated rat. Legal Med 2006; 8: 16–21
   PubMedGoogle Scholar
• Curtis E K. Meth mouth: a review of methamphetamine abuse and its oral manifestations. Gen Dent 2006; 54: 125–129
   PubMedGoogle Scholar
• Saini T, Edwards P C, Kimmes N S, Carroll L R, Shaner J W, Dowd F J. Etiology of xerostomia and dental caries among methamphetamine abusers. Oral Health Prev Dent 2005; 3: 189–195
   PubMedGoogle Scholar
• Kaye S, Darke S. A comparison of the harms associated with the injection of heroin and amphetamines. Drug Alcohol Depend 2000; 58: 189–195
   PubMed Web of Science ®Google Scholar
• Verachai V, Phutiprawan T, Theamboonlers A, et al. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 849–851
   PubMedGoogle Scholar
• Wada K, Greberman S B, Konuma K, Hirai S. HIV and HCV infection among drug users in Japan. Addiction 1999; 94: 1063–1069
   PubMed Web of Science ®Google Scholar
• Buchacz K, McFarland W, Kellogg T A, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005; 19: 1423–1424
   PubMed Web of Science ®Google Scholar
• Koblin B A, Husnik M J, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS 2006; 20: 731–739
   PubMed Web of Science ®Google Scholar
• Hirshfield S, Remien R H, Walavalkar I, Chiasson M A. Crystal methamphetamine use predicts incident STD infection among men who have sex with men recruited online: a nested case – control study. J Med Internet Res 2004; 6: e41
   PubMed Web of Science ®Google Scholar
• Baker A, Boggs T G, Lewin T J. Characteristics of regular amphetamine users and implications for treatment. Drug Alcohol Rev 2001; 20: 49–56
   Web of Science ®Google Scholar
• Kilbourne A M, McCarthy J F, Welsh D, Blow F. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis 2006; 194: 598–602
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: detailed findings. Drug Statistics Series 16. Australian Institute of Health and Welfare, Canberra 2005
   Google Scholar
• Pantiga C, Rodrigo L R, Cuesta M, Lopez L, Arias J L. Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatry Clin Neurosci 2003; 15: 84–89
   PubMed Web of Science ®Google Scholar
• Greenwell L, Brecht M-L. Self-reported health status among treated methamphetamine users. Am J Drug Alcohol Abuse 2003; 29: 75–104
   PubMed Web of Science ®Google Scholar
• Vincent N, Shoobridge J, Ask A, Allsop S, Ali R. Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug Alcohol Rev 1998; 17: 187–195
   PubMed Web of Science ®Google Scholar
• Sommers I, Baskin D, Baskin-Sommers A. Methamphetamine use among young adults: health and social consequences. Addict Behav 2006; 31: 1469–1476
   PubMed Web of Science ®Google Scholar
• Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug Alcohol Rev 1994; 13: 277–284
   PubMedGoogle Scholar
• Garrity T F, Leukefeld D SW, Carlson R G, Falck J W, Booth B M. Phsycial health, illicit drug use and demographic characteristics in rural stimulant users. Nat Rural Health Assoc 2007; 23: 99–107
   PubMed Web of Science ®Google Scholar
• Darke S. Polydrug use and overdose: overthrowing old myths. Addiction 2003; 98: 711
   PubMed Web of Science ®Google Scholar
• Darke S, Hall W. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 1995; 39: 231–235
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend 1997; 48: 135–141
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Day C, Dietze P, et al. Effects of a sustained heroin shortage in three Australian States. Addiction 2005; 100: 908–920
   PubMed Web of Science ®Google Scholar
• Ware J E, Kosinksi M MA, Keller S D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–233
   PubMed Web of Science ®Google Scholar
• Burdine J N, Felix M JR, Abel A L, Wiltraut C J, Musselman Y J. The SF-12 as a population health measure: an exploratory examination of potential for application. Health Serv Res 2000; 35: 885–904
   PubMed Web of Science ®Google Scholar
• Sanderson K, Andrews G. Prevalence and severity of mental health-related impairment and relationship to diagnosis. Psychiatr Serv 2002; 53: 80–86
   PubMed Web of Science ®Google Scholar
• Andrews G. A brief integer scorer for the SF-12: validity of the brief scorer in Australian community and clinic settings. Aust NZ J Public Health 2002; 26: 508–510
   PubMed Web of Science ®Google Scholar
• Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The Severity of Dependence Scale (SDS) in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607–614
   PubMed Web of Science ®Google Scholar
• Topp L, Mattick R P. Choosing a cutoff on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997; 92: 839–845
   PubMed Web of Science ®Google Scholar
• Ware J E, Kosinksi M MA, Keller S D. How to score the SF-12 Physical and Mental Health Summary Scales, 2nd edn. The Health Institute, New England Medical Centre, Boston 1995
   Google Scholar
• Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability, and service utilisation: overview of the Australian National Mental Health Survey. Br J Psychiatry 2001; 178: 145–153
   PubMed Web of Science ®Google Scholar
• STATA Corporation. Intercooled STATA version 8.0 for Windows. STATA Corporation, Texas 2003
   Google Scholar
• Case A, Paxson C. Sex differences in morbidity and mortality. Demography 2005; 42: 189–214
   PubMed Web of Science ®Google Scholar
• Spiers N, Jagger C, Clarke M, Arthur A. Are gender differences in the relationship between self-rated health and mortality enduring? Results from three birth cohorts in Melton Mowbray, United Kingdom. Gerontologist 2003; 43: 406–411
   PubMed Web of Science ®Google Scholar
• McKetin R, Kelly E. Socio-demographic predictors of methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug Alcohol Rev 2007; 25: 161–168
   Web of Science ®Google Scholar
• Johnson E M. Has the SF-36's role physical measure fallen short?. J Public Health Med 1999; 21: 234
   PubMedGoogle Scholar